{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:44:26Z","timestamp":1761965066472},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>A wide spectrum of heterogeneous conditions can render a patient immunocompromised. Recent years have seen an increase in the number of immunocompromised patients given the earlier detection of conditions that require immunosuppressive therapies, changes in immunosuppressive regimens leading to increased survival or novel therapeutic advancements in oncologic care. Acute respiratory failure (ARF) is the leading cause of critical illness and mortality in this population. This review highlights the spectrum of causes of ARF in immunocompromised patients with a particular focus on acute toxicities of novel oncologic treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent years have seen improved survival amongst critically ill immunocompromised patients with ARF. This is likely attributable to patient selection of immunosuppressive therapy, improved noninvasive microbiologic diagnostic techniques, improved antimicrobial prophylaxis, treatment, stewardship, and advancements in supportive care including intensive care. Infectious complications remain the leading cause of ARF in this population. However, one of the greatest challenges physicians continue to face is accurate identification of the cause of ARF, given the vast (and increasing) noninfectious causes of ARF across these patients. Emerging therapies, such as immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell therapy (CAR T-cell) have contributed to this problem. Finally, undetermined ARF is reported in approximately 13% of immunocompromised and is associated with a worse prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Infectious complications are still the leading cause of ARF in immunocompromised patients. However, noninfectious complications, derived from the underlying disease or treatment, should be always considered, including novel therapies, such as ICIs and CAR T cells. Further research should focus in improving the diagnostic rate in this subgroup.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000569","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T06:16:52Z","timestamp":1543990612000},"page":"21-28","source":"Crossref","is-referenced-by-count":7,"title":["Causes of acute respiratory failure in the immunocompromised host"],"prefix":"10.1097","volume":"25","author":[{"given":"Bruno L.","family":"Ferreyro","sequence":"first","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, Department of Medicine, Mount Sinai Hospital\/University Health Network, University of Toronto, Ontario, Canada"},{"name":"Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laveena","family":"Munshi","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, Department of Medicine, Mount Sinai Hospital\/University Health Network, University of Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.blre.2015.04.002","article-title":"Managing critically ill hematology patients: time to think differently","volume":"29","author":"Azoulay","year":"2015","journal-title":"Blood Rev"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium\u2014a Groupe de Recherche Respiratoire en R\u00e9animation Onco-H\u00e9matologique Study","volume":"31","author":"Azoulay","year":"2013","journal-title":"J Clin Onc"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00134-014-3354-0","article-title":"Acute respiratory distress syndrome in patients with malignancies","volume":"40","author":"Azoulay","year":"2014","journal-title":"Intensive Care Med"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17476348.2018.1511430","article-title":"The challenge of avoiding intubation in immunocompromised patients with acute respiratory failure","volume":"12","author":"De Jong","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0749-0704(05)70201-3","article-title":"Acute respiratory failure in critically ill patients with cancer. Diagnosis and management","volume":"17","author":"Pastores","year":"2001","journal-title":"Crit Care Clin"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00134-014-3433-2","article-title":"Has survival increased in cancer patients admitted to the ICU? Yes","volume":"40","author":"Mokart","year":"2014","journal-title":"Intensive Care Med"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/jama.2016.2762","article-title":"Immunosuppression and secondary infection in sepsis","volume":"315","author":"Angus","year":"2016","journal-title":"JAMA"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/rccm.200309-1322SO","article-title":"Pulmonary complications of solid organ and hematopoietic stem cell transplantation","volume":"170","author":"Kotloff","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00134-017-4947-1","article-title":"Acute hypoxemic respiratory failure in immunocompromised patients: the EFRAIM multinational prospective cohort study","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0272-5231(03)00121-7","article-title":"Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment","volume":"25","author":"Yen","year":"2004","journal-title":"Clin Chest Med"},{"issue":"(Suppl 4)","key":"R11-20230913","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.12093","article-title":"Introduction: infections in solid organ transplantation","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jrid.2016.11.001","article-title":"Respiratory infections in immunocompromised patients: lung findings using chest computed tomography","volume":"4","author":"Bajaj","year":"2017","journal-title":"Radiol Infect Dis"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00134-006-0129-2","article-title":"Diagnostic strategy in cancer patients with acute respiratory failure","volume":"32","author":"Azoulay","year":"2006","journal-title":"Intensive Care Med"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00134-014-3368-7","article-title":"What's new in diagnosis and antimicrobial therapy of febrile neutropenic patients with lung infiltrates?","volume":"40","author":"Rieger","year":"2014","journal-title":"Intensive Care Med"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00134-014-3254-3","article-title":"What's new in invasive pulmonary aspergillosis in the critically ill","volume":"40","author":"Koulenti","year":"2014","journal-title":"Intensive Care Med"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"R18-20230913","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201712-2452OC","article-title":"A multivariable prediction model for pneumocystis jirovecii pneumonia in hematology patients with acute respiratory failure","author":"Azoulay","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4067\/S0716-10182015000300006","article-title":"Pneumocystis jiroveci infection in patients with and without HIV: a comparison","volume":"32","author":"Rey","year":"2015","journal-title":"Rev Chilena Infectol Sociedad Chilena de Infectolog\u00eda"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/jac\/dkw155","article-title":"Pneumocystis jiroveciipneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Cordonnier","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/rccm.201001-0018OC","article-title":"Diagnostic strategy for hematology and oncology patients with acute respiratory failure","volume":"182","author":"Azoulay","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1378\/chest.11-2103","article-title":"Drug-associated acute lung injury","volume":"142","author":"Dhokarh","year":"2012","journal-title":"Chest"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccm.2004.05.006","article-title":"Drug-induced and iatrogenic infiltrative lung disease","volume":"25","author":"Camus","year":"2004","journal-title":"Clin Chest Med"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11864-018-0562-9","article-title":"Treatment of complications from immune checkpoint inhibition in patients with lung cancer","volume":"19","author":"Wills","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/CCM.0000000000003258","article-title":"Management of the critically ill adult chimeric antigen receptor-T cell therapy patient","volume":"46","author":"Gutierrez","year":"2018","journal-title":"Cri Care Med"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s10147-018-1259-6","article-title":"Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update","volume":"23","author":"Nagai","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/jamaoncol.2016.2453","article-title":"Incidence of programmed cell death 1 inhibitor related pneumonitis in patients with advanced cancer: a systematic review and meta-analysis","volume":"2","author":"Nishino","year":"2016","journal-title":"JAMA Oncol"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1056\/NEJMe1714680","article-title":"A milestone for CAR T Cells","volume":"377","author":"Tran","year":"2017","journal-title":"N Engl J Med"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy: assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccc.2009.10.001","article-title":"Acute respiratory failure in the patient with cancer: diagnostic and management strategies","volume":"26","author":"Pastores","year":"2010","journal-title":"Crit Care Clin"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.chest.2015.11.004","article-title":"Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis","volume":"149","author":"Seguin","year":"2016","journal-title":"Chest"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/CCM.0000000000001617","article-title":"Epidemiology of acute respiratory distress syndrome following hematopoietic stem cell transplantation","volume":"44","author":"Yadav","year":"2016","journal-title":"Crit Care Med"},{"key":"R36-20230913","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","article-title":"An official American Thoracic Society Research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome","volume":"183","author":"Panoskaltsis-Mortari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R37-20230913","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bbmt.2017.11.039","article-title":"Diagnostic and prognostic plasma biomarkers for idiopathic pneumonia syndrome after hematopoietic cell transplantation","volume":"24","author":"Seo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"R38-20230913","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13054-018-2079-9","article-title":"Immunocompromised patients with acute respiratory distress syndrome: a secondary analysis of the LUNG SAFE database","volume":"22","author":"Cortegiani","year":"2018","journal-title":"Critical Care"},{"key":"R39-20230913","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MCC.0000000000000572","article-title":"Rare respiratory diseases in the ICU: when to suspect them and specific approaches","volume":"25","author":"Gibelin","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"R40-20230913","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12630-017-1041-7","article-title":"The utility and safety of flexible bronchoscopy in critically ill acute leukemia patients: a retrospective cohort study","volume":"65","author":"Deotare","year":"2018","journal-title":"Can J Anaesth"},{"key":"R41-20230913","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12890-015-0104-1","article-title":"Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients","volume":"15","author":"Schnabel","year":"2015","journal-title":"BMC Pulm Med"},{"key":"R42-20230913","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1164\/rccm.201707-1474OC","article-title":"Novel method for noninvasive sampling of the distal airspace in acute respiratory distress syndrome","volume":"197","author":"McNeil","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075198-201902000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:16:48Z","timestamp":1694632608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075198-201902000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000569","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}